BRIEF-Core Laboratories Inc - Q3 2025 Revenue Of $134.5 Million - SEC Filing

Reuters10-23

Oct 22 (Reuters) - Core Laboratories Inc CLB.N:

CORE LABORATORIES INC - Q3 2025 REVENUE OF $134.5 MILLION - SEC FILING
CORE LABORATORIES INC: QTRLY EPS EX-ITEMS, $0.22
CORE LABORATORIES INC: OUTLOOK Q4 REVENUE $132 MILLION - $136 MILLION; OUTLOOK Q4 EPS $0.18 TO $0.22

Source text: [ID:n0001193125-25-246793]

Further company coverage: CLB.N

((Reuters.Briefs@thomsonreuters.com;))

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap

Leave a comment

{"i18n":{"language":"en_US"},"isChannel":false,"data":{"share":"https://ttm.financial/m/news/2577831458?lang=en_US&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2025-10-23 04:57","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"2577831458","market":"nz","top_or_hot":-1,"title":"BRIEF-Core Laboratories Inc - Q3 2025 Revenue Of $134.5 Million - SEC Filing","media":"Reuters","content":"<html xmlns=\"http://www.w3.org/1999/xhtml\"><head><title>BRIEF-Core Laboratories Inc - Q3 2025 Revenue Of $134.5 Million - SEC Filing</title></head><body><p><span>Oct 22 (Reuters)</span><span> - </span>Core Laboratories Inc <span>CLB.N</span>:</p><ul><li><p><a href=\"https://laohu8.com/S/CLB\">CORE LABORATORIES INC</a> - Q3 2025 REVENUE OF $134.5 MILLION - SEC FILING</p></li><li><p>CORE LABORATORIES INC: QTRLY EPS EX-ITEMS, $0.22</p></li><li><p>CORE LABORATORIES INC: OUTLOOK Q4 REVENUE $132 MILLION - $136 MILLION; OUTLOOK Q4 EPS $0.18 TO $0.22</p></li></ul><p>Source text: [ID:n0001193125-25-246793]</p><p>Further company coverage: <span>CLB.N</span></p><p> ((Reuters.Briefs@thomsonreuters.com;))</p></body></html>","source":null,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>BRIEF-Core Laboratories Inc - Q3 2025 Revenue Of $134.5 Million - SEC Filing</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nBRIEF-Core Laboratories Inc - Q3 2025 Revenue Of $134.5 Million - SEC Filing\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1032215980\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://community-static.tradeup.com/news/4567337cbdf294b657b1fa87c5488b48);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Reuters </p>\n<p class=\"h-time\">2025-10-23 04:57</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<html xmlns=\"http://www.w3.org/1999/xhtml\"><head><title>BRIEF-Core Laboratories Inc - Q3 2025 Revenue Of $134.5 Million - SEC Filing</title></head><body><p><span>Oct 22 (Reuters)</span><span> - </span>Core Laboratories Inc <span>CLB.N</span>:</p><ul><li><p><a href=\"https://laohu8.com/S/CLB\">CORE LABORATORIES INC</a> - Q3 2025 REVENUE OF $134.5 MILLION - SEC FILING</p></li><li><p>CORE LABORATORIES INC: QTRLY EPS EX-ITEMS, $0.22</p></li><li><p>CORE LABORATORIES INC: OUTLOOK Q4 REVENUE $132 MILLION - $136 MILLION; OUTLOOK Q4 EPS $0.18 TO $0.22</p></li></ul><p>Source text: [ID:n0001193125-25-246793]</p><p>Further company coverage: <span>CLB.N</span></p><p> ((Reuters.Briefs@thomsonreuters.com;))</p></body></html>\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"CLB","symbol_name":"CORE LABORATORIES INC","start_time":0,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251022:nFWN3W337I:1","article_id":"2577831458","we_media_id":"1032215980","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=2577831458","pubTimestamp":1761166678,"columns":[],"sourceInfo":null,"weMediaInfo":{"media_name":"Reuters","introduction":"Reuters.com brings you the latest news from around the world, covering breaking news in markets, business, politics, entertainment and technology","home_visible":1,"id":"1032215980","head_image":"https://community-static.tradeup.com/news/4567337cbdf294b657b1fa87c5488b48"},"summary":"BRIEF-Core Laboratories Inc - Q3 2025 Revenue Of $134.5 Million - SEC FilingOct 22  - Core Laboratories Inc CLB.N:CORE LABORATORIES INC - Q3 2025 REVENUE OF $134.5 MILLION - SEC FILINGCORE LABORATORIES INC: QTRLY EPS EX-ITEMS, $0.22CORE LABORATORIES INC: OUTLOOK Q4 REVENUE $132 MILLION - $136 MILLION; OUTLOOK Q4 EPS $0.18 TO $0.22Source text: [ID:n0001193125-25-246793]Further company coverage: CLB.N ","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"CLB":"CORE LABORATORIES INC","BK4179":"石油天然气设备与服务"},"translate_title":"简介-Core Laboratories Inc-2025年第三季度收入为1.345亿美元-SEC备案","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"CLB":0.9},"content_text":"BRIEF-Core Laboratories Inc - Q3 2025 Revenue Of $134.5 Million - SEC FilingOct 22 (Reuters) - Core Laboratories Inc CLB.N:CORE LABORATORIES INC - Q3 2025 REVENUE OF $134.5 MILLION - SEC FILINGCORE LABORATORIES INC: QTRLY EPS EX-ITEMS, $0.22CORE LABORATORIES INC: OUTLOOK Q4 REVENUE $132 MILLION - $136 MILLION; OUTLOOK Q4 EPS $0.18 TO $0.22Source text: [ID:n0001193125-25-246793]Further company coverage: CLB.N ((Reuters.Briefs@thomsonreuters.com;))","kind":"highlight","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"0","news_tag":"dataReport,express","news_rank":0,"symbols":[],"gpt_button":1,"need_auth":false,"code":"91000000","status":"200"},"commentList":[],"isCommentEnd":true,"newsSizeData":{"likeSize":0,"commentSize":0,"repostSize":0,"favoriteSize":0,"likeStatus":false,"favoriteStatus":false},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":true,"deviceId":"web-server-community-laohu8-v3","version":"4.35.12","shortVersion":"4.35.12","platform":"web","vendor":"web","appName":"ttm","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"href":"/m/news/2577831458","isCrawlerRequest":true}